Clinical Trial Update: Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating chemo-immunotherapy with hypo-fractionated radiotherapy followed by maintenance immunotherapy for Stage III non-small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: NSCLC, Stage III | Phase 2 | Status: UNKNOWN